Companies
Wednesday, 6/24, 08:32 AM
Takeda Names Julie Kim CEO, Capping an 18-Month Transition From Weber
- Takeda Pharmaceutical, Japan's largest drugmaker, formally appointed Julie Kim as president and chief executive on June 24, completing an 18-month handover from Christophe Weber and elevating a former U.S.
- business chief to the top of a company managing major patent expirations.